Ionis Pharmaceuticals (IONS)
(Real Time Quote from BATS)
$41.87 USD
+0.77 (1.87%)
Updated Apr 23, 2024 10:54 AM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Ionis Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -366.29 | -269.72 | -28.60 | -486.77 | 303.26 |
Depreciation/Amortization & Depletion | -0.06 | 34.87 | 42.29 | 67.42 | 47.79 |
Net Change from Assets/Liabilities | -77.26 | 7.57 | -113.82 | -73.56 | -168.71 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 136.09 | -47.09 | 130.92 | 528.80 | 163.38 |
Net Cash From Operating Activities | -307.51 | -274.37 | 30.80 | 35.89 | 345.72 |
Property & Equipment | -23.78 | 238.36 | -11.96 | -35.12 | -30.91 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -186.14 | -496.62 | 212.81 | 315.53 | -4.99 |
Other Investing Activities | -4.21 | -4.38 | -5.95 | -5.93 | -5.38 |
Net Cash from Investing Activities | -214.13 | -262.64 | 194.91 | 274.48 | -41.27 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 49.44 | 6.37 | 101.32 | -38.51 | 141.38 |
Issuance (Repayment) of Debt | 86.90 | -50.69 | 176.95 | 0.00 | -22.11 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 507.74 | -10.98 | -32.33 | -558.10 | -19.24 |
Net Cash from Financing Activities | 644.08 | -55.30 | 245.93 | -596.61 | 100.02 |
Effect of Exchange Rate Changes | 0.35 | -0.42 | -0.11 | 0.62 | 0.00 |
Net Change In Cash & Equivalents | 122.79 | -592.72 | 471.53 | -285.62 | 404.47 |
Cash at Beginning of Period | 276.47 | 869.19 | 397.66 | 683.29 | 278.82 |
Cash at End of Period | 399.27 | 276.47 | 869.19 | 397.66 | 683.29 |
Diluted Net EPS | -2.56 | -1.90 | -0.20 | -3.23 | 2.08 |
Fiscal Year End for Ionis Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -366.29 | -357.02 | -209.61 | -124.32 |
Depreciation/Amortization & Depletion | NA | -0.06 | 1.16 | 1.78 | 2.05 |
Net Change from Assets/Liabilities | NA | -77.26 | -90.25 | -86.57 | -55.00 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 136.09 | 105.74 | 63.05 | 43.29 |
Net Cash From Operating Activities | NA | -307.51 | -340.38 | -231.36 | -133.99 |
Property & Equipment | NA | -23.78 | -24.62 | -22.48 | -10.47 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | -1.25 |
Investments | NA | -186.14 | -159.38 | -231.33 | -313.92 |
Other Investing Activities | NA | -4.21 | -3.41 | -2.31 | 0.00 |
Net Cash from Investing Activities | NA | -214.13 | -187.41 | -256.13 | -325.64 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 49.44 | 8.68 | 4.95 | 2.56 |
Issuance (Repayment) of Debt | NA | 86.90 | 72.76 | 141.11 | -0.04 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 507.74 | 521.92 | 489.57 | 489.57 |
Net Cash from Financing Activities | NA | 644.08 | 603.36 | 635.63 | 492.09 |
Effect of Exchange Rate Changes | NA | 0.35 | 0.02 | 0.17 | 0.10 |
Net Change In Cash & Equivalents | NA | 122.79 | 75.59 | 148.32 | 32.56 |
Cash at Beginning of Period | NA | 276.47 | 276.47 | 276.47 | 276.47 |
Cash at End of Period | NA | 399.27 | 352.06 | 424.79 | 309.03 |
Diluted Net EPS | NA | -0.06 | -1.03 | -0.60 | -0.87 |